Mimedx (MDXG) Revenue Growth (1y) (2012 - 2026)
Mimedx (MDXG) Revenue Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Mimedx | 639.06 Mn | 479.29 Mn | 41.62 Mn | -33.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.12% |
| Dec 31, 2025 | 27.11% |
| Sep 30, 2025 | 35.30% |
| Jun 30, 2025 | 13.07% |
| Mar 31, 2025 | 4.13% |
| Dec 31, 2024 | 7.00% |
| Sep 30, 2024 | 2.87% |
| Jun 30, 2024 | 7.32% |
| Mar 31, 2024 | 18.18% |
| Dec 31, 2023 | 16.75% |
| Sep 30, 2023 | 20.72% |
| Jun 30, 2023 | 21.49% |
| Mar 31, 2023 | 21.70% |
| Dec 31, 2022 | 46.37% |
| Sep 30, 2022 | 7.32% |
| Jun 30, 2022 | -1.88% |
| Mar 31, 2022 | -1.79% |
| Dec 31, 2021 | -25.87% |
| Sep 30, 2021 | -1.91% |
| Jun 30, 2021 | 27.06% |